An imbalance in gene activity in two types of immune cells explains why lung fibrosis after a severe COVID-19 infection doesn ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

BOISE — Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause on certain types of vaccines that were used ...

Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that it ...

The same mechanisms involved in COVID-related cardiovascular events are responsible for COVID-related myocarditis.

During the COVID-19 pandemic, health worker Maria Tereza Malheiros Sapienza's curiosity was aroused by her immunity to ...

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...

Robert F. Kennedy Jr., the HHS secretary nominee, has said he is not antivaccine, but he has a track record of casting doubt ...

January 2025 marks five years since the beginning of the COVID-19 pandemic that resulted in 1,216,305 American deaths and ...

The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.

Even though people may be getting better at fighting the illness, COVID-19 is still dangerous to vulnerable groups. And so ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of ...